Method of imaging colorectal carcinoma lesion and composition for use therein
US5431897A · kind A · utility
18Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 1993 |
| Grant date | Jul 11, 1995 |
| Priority date | — |
| Expiry date | Feb 16, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/837
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method of imaging a colorectal carcinoma lesion in a human patient which comprises administering to the patient a monoclonal antibody capable of binding to a cell surface antigen associated with the colorectal carcinoma lesion and which is labeled with an imaging agent under conditions so as to form a complex between the monoclonal antibody and the cell surface antigen, imaging any complex so formed, and thereby imaging the colorectal carcinoma lesion. This invention also provides a monoclonal antibody designated AS 33 (ATCC Accession No. HB 8779) and the hybridoma which produces it.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.